GE Medical Systems of Milwaukee has received Food and Drug Administrationclearance for two new mammography systems, Senographe 700-T andSenographe 800-T. The systems were introduced at last year's RadiologicalSociety of North America meeting and are
GE Medical Systems of Milwaukee has received Food and Drug Administration
clearance for two new mammography systems, Senographe 700-T and
Senographe 800-T. The systems were introduced at last year's Radiological
Society of North America meeting and are designed to occupy price
points below that of the premium Senographe DMR (SCAN 12/27/95).
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.